The European Database on Medical Devices (EUDAMED) is set to become an essential tool for medical device authorities and manufacturers. Originally proposed several years ago, its implementation has faced multiple delays. However, recent updates provide clarity on the final implementation dates that all companies selling medical devices into the EU must be aware of.
Many manufacturers may have already volunteered to register as an Actor within the database, maintaining public information such as the assigned person responsible for regulatory compliance and legal manufacturer address.
The lates public plan from the European Commission outlines the roadmap for release of EUDAMED’s full functionality, marking crucial dates for manufacturers and other stakeholders where EUDAMED use moves from voluntary to legally required.
Key dates for EUDAMED implementation:
January 2026: the Actor and Device Certification Modules will become mandatory. This includes registration for manufacturers and EU authorized representatives, as well as certification processes involving notified bodies.
July 2026: The Vigilance Module and Unique Device Identification (UDI) registration for all devices sold in the EU will be mandatory.
These modules are critical for ensuring transparency, traceability, and vigilance in the EU medical device market.
What is EUDAMED?
EUDAMED is a secure, web-based portal provided by the European Commission. It aims to enhance transparency and coordination in the medical devices sector by providing a central point of access for various stakeholders, including manufacturers, EU Authorised Representatives, importers, Notified Bodies and competent authorities.
EUDAMED consists of several interconnected modules, each designed to handle specific aspects of medical device regulation: the Actor Registration Module, UDI/Device Registration Module, Notified Bodies and CertificatesModule, Clinical Investigations and Performance Studies Module, Vigilance and Post-market Surveillance Module and Market Surveillance Module.
What manufacturers need to do
For manufacturers, especially those with extensive and complex product portfolios, preparing for EUDAMED’s requirements involves several critical steps:
- Understanding UDI Requirements: the UDI system is designed to improve the identification and traceability of medical devices. Each product’s UDI record will need to be meticulously maintained and updated in the EUDAMED database. This includes a significant amount of detailed information for each device. Manufacturers already selling into the USA may already be familiar with many of the UDI requirements, which are similar to those of the FDA GUDID device registration database.
- Collecting and Managing UDI Data: manufacturers need to develop robust internal systems to collect, manage, and maintain UDI data For each device sold into the EU. This involves ensuring that all relevant data is accurate, comprehensive, and readily available for upload to the EUDAMED database.
- Planning for Data Upload: begin planning now for how your organization will handle the upload and maintenance of UDI data on the EUDAMED database. This involves setting up processes and possibly new technologies to streamline data management and ensure compliance with the upcoming requirements.
EUDAMED implementation: what will change for vigilance reporting
The EUDAMED platform will significantly enhance the ability of regulatory authorities to monitor the market, track the performance of medical devices, and respond quickly to any issues.
Currently reporting of serious incidents which have or could potentially cause serious harm or death are performed in each individual EU member state, using a specialised smart PDF called the Manufacturer Incident Report Form, or national reporting software tools. With a fully functioning EUDAMED vigilance reporting will be centralised within the EUDAMED database, improving the efficiency of identifying who and how to report an incident to through automation. This database module will also be used to perform other post market actions, such as notification and dissemination of Field Safety Corrective Action and Recalls, Periodic Incident Trend Reporting and upload of particular Post Market Surveillance documentation.
The forthcoming implementation of EUDAMED represents a significant milestone for the EU medical device market. Manufacturers must take proactive steps to ensure they are prepared for these changes. By understanding the requirements, collecting and managing UDI data effectively, and planning for compliance, manufacturers can navigate this transition smoothly and continue to provide safe, effective medical devices to the European market.
For detailed information on the EUDAMED roadmap and implementation plan, refer to the European Commission’s public plan and visit the EUDAMED portal.